VTRS FY 2012 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$6.8B+10.9% YoY

Gross Profit

$2.9B42.8% margin

Operating Income

$1.1B16.3% margin

Net Income

$641M9.4% margin

EPS (Diluted)

$1.52

Cash Flow

Operating Cash Flow

$949M

Free Cash Flow

$644M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.9B

Total Liabilities

$8.6B

Stockholders' Equity

$3.3B

Cash & Equivalents

$350M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.8B	$6.1B	+10.9%
Gross Profit	$2.9B	$2.6B	+13.5%
Operating Income	$1.1B	$1.0B	+10.3%
Net Income	$641M	$537M	+19.4%